ВЛИЯНИЕ ОМАКОРА НА ВАРИАБЕЛЬНОСТЬ СЕРДЕЧНОГО РИТМА И ИШЕМИЧЕСКИЕ ИЗМЕНЕНИЯ В МИОКАРДЕ У БОЛЬНЫХ ХРОНИЧЕСКОЙ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА В СОЧЕТАНИИ С САХАРНЫМ ДИАБЕТОМ 2 ТИПА

We have studied effect of Omacor in the treatment of patients with chronic coronary heart disease (CHD) with diabetes mellitus (DM) type 2 on heart rate variability (HRV) and the severity of ischemic processes in myocardium. It is shown that Omacor taking (1 g/day) in the complex therapy for 3 month...

Full description

Saved in:
Bibliographic Details
Main Authors: В. П. Михин (Author), Л. С. Мальцева (Author)
Format: Book
Published: SINAPS LLC, 2013-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have studied effect of Omacor in the treatment of patients with chronic coronary heart disease (CHD) with diabetes mellitus (DM) type 2 on heart rate variability (HRV) and the severity of ischemic processes in myocardium. It is shown that Omacor taking (1 g/day) in the complex therapy for 3 months leads to improvement of HRV (time and frequency), with more pronounced positive effect in patients without postinfarction cardiosclerosis. Admission of Omacor increases antianginal effects of nitrates and beta-blockers, reduces necessity of using a short-acting nitrates to relieve angina. It allows to recommend to include Omacor in complex treatment of patients with chronic CHD and type 2 DM in order to improve HRV, as well as improving the effectiveness of key antianginal agents.
Item Description:2226-6704
2411-6564
10.20514/2226-6704-2013-0-1-25-32